Quantcast

Latest Barbara Ann Karmanos Cancer Institute Stories

2011-01-13 09:13:00

DETROIT, Jan. 13, 2011 /PRNewswire/ -- A clinical research study to develop a rapid and inexpensive blood screening test for the early diagnosis of pancreatic cancer has been launched by Henry Ford Health System and the Barbara Ann Karmanos Cancer Institute. Funding for the study was provided by Sky Foundation, Inc., a local non-profit dedicated to raising awareness and funds for the early detection of pancreatic cancer. Henry Ford will recruit 300 patients to participate in this study...

2010-11-12 14:36:00

$4 Million National Cancer Institute Grant Spurs Southeast Michigan Partners Against Cancer DETROIT, Nov. 12, 2010 /PRNewswire-USNewswire/ -- Three institutions dedicated to health, innovative science and quality cancer care announced today the creation of the Southeast Michigan Partners Against Cancer (SEMPAC) to help close the gap on racial disparities related to cancer care in southeast Michigan. SEMPAC is made possible by a more than $4 million, five-year grant from the National...

2010-10-29 13:05:00

Abstract # 1586 SAN DIEGO, Oct. 29 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting. (Logo:...

2010-10-28 14:19:00

Abstracts # 2672 and 2682 SAN DIEGO, Oct. 28 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) - a form of radiation that is about three times more powerful than typical photon radiotherapy - is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are...

2010-10-28 13:56:00

Abstract # 3179 SAN DIEGO, Oct. 28 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and...

2010-10-22 11:12:00

ADDRESSING NATIONAL SHORTAGE OF MINORITY CORD BLOOD DETROIT, Oct. 22 /PRNewswire-USNewswire/ -- The J.P. McCarthy Cord Stem Cell Bank at the Barbara Ann Karmanos Cancer Institute will receive a $1.4 million, three-year, contract award from the Department of Health and Human Services' Health Resources and Services Administration (HRSA) to expand its cord blood collection program. The contract will allow Karmanos to bank more genetically-diverse, high-quality umbilical cord blood units for...

2010-10-18 15:48:00

DETROIT, Oct. 18 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer - triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute. (Logo:...

2010-09-23 11:43:00

2010 Komen Detroit Race for the Cure® Accomplishments DETROIT, Sept. 23 /PRNewswire-USNewswire/ -- Susan G. Komen Detroit Race for the Cure® announced that it has awarded more than $1.5 million to local breast cancer education, screening and treatment programs as a result of $2.3 million raised in the 2010 Komen Detroit Race for the Cure®, locally presented by the Barbara Ann Karmanos Cancer Institute. The announcement was made...

2010-09-15 15:06:00

DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center in Detroit was recently selected to be one of 50 sites in the United States to offer the new U.S. Food and Drug Administration (FDA)-approved drug PROVENGE® (sipuleucel-T) to treat patients with advanced metastatic prostate cancer. (Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) PROVENGE, manufactured by...

2010-09-08 11:16:00

BEVERLY HILLS, Calif., Sept. 8 /PRNewswire/ -- Tower Cancer Research Foundation, a nonprofit organization dedicated to cutting edge cancer therapy and research, will host the first in a series of free symposiums on October 19. The 2010 Tower Oncology Fall Cancer Symposium - Advances in Breast Cancer Research and Treatment: A Multidisciplinary Panel Discussion - will take place from 6:30-8:30pm at Wolfgang's Steakhouse on 445 N. Canon Drive in Beverly Hills. The symposium will feature...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related